Largest Pharmacy-Benefit Managers Hiked Up Drug Prices, FTC Says
The markups helped the pharmacy-benefit managers reap $7.3 billion from 2017 to 2022, the FTC found.
FTC finds middlemen inflate specialty generic drug prices by billions of dollars
Pharmacy benefit managers, which serve as the middlemen between drug makers, insurers and pharmacies, reaped $7.3 billion in revenue from marking up the prices of dozens of specialty generic drugs ...